Decision Aid for Indomethacin Therapy in Preterm Infants
Author Information
Author(s): Khalid M AlFaleh, Eman AlLuwaimi, Turki M AlKharfi, Saleh A Al-Alaiyan
Primary Institution: King Saud University
Hypothesis
Can a decision aid improve parental preferences regarding indomethacin therapy for extreme low birth weight infants?
Conclusion
The study developed a computer-based decision aid to help parents make informed choices about indomethacin therapy for their preterm infants.
Supporting Evidence
- The decision aid was positively rated by volunteers on 10 out of 13 items.
- There was a significant improvement in knowledge and decisional conflict scales after using the decision aid.
- The mean time to complete the decision aid was 19 minutes.
Takeaway
This study created a tool to help parents understand their options for treating their premature babies, making it easier for them to decide what to do.
Methodology
The decision aid was developed using the Ottawa Decision Support Framework and tested with parents through questionnaires and scales.
Potential Biases
The reliance on self-reported data from parents may introduce bias.
Limitations
The pilot testing involved a small sample size, which may limit the generalizability of the results.
Participant Demographics
{"mean_age":36.2,"education_levels":{"less_than_high_school":1,"high_school":1,"college":2,"graduate_degree":6},"computer_user":8,"internet_user":8}
Statistical Information
P-Value
0.008
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website